Takeda to present late-breaking TAK-921 data at ESMO 2026
Takeda said new oncology pipeline and portfolio data will be presented at ESMO Congress Oct. 23–27, 2026, in Madrid, including a late-breaking abstract on arcotatug tavatecan (TAK-921).
Takeda said new oncology pipeline and portfolio data will be presented at ESMO Congress Oct. 23–27, 2026, in Madrid, including a late-breaking abstract on arcotatug tavatecan (TAK-921).